Merck MRK
NYSE MRK
$149.18 -3.05 (-2.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Merck (MRK) Gross Margin (2009 - 2026)

Merck (MRK) posted quarterly Gross Margin of 74.24% for Q1 2026, down 374.0% year-over-year from 27.1% in Q1 2025, and up 12.23% quarter-over-quarter from 66.15% in Q4 2025.

Merck (MRK) Gross Margin (2009 - 2026) Analysis & Trends

Merck (MRK) has reported Gross Margin for 18 consecutive years, with 74.24% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Gross Margin fell 374.0% year-over-year to 74.24%; the TTM figure through Mar 2026 stood at 73.91% (down 251.0% YoY), while the FY2025 annual figure was 74.8%, down 152.0% from the prior year.
  • Gross Margin improved to 74.24% in Q1 2026 per MRK's latest filing, from 66.15% in the prior quarter.
  • Across five years, Gross Margin topped out at 77.98% in Q1 2025 and bottomed at 66.15% in Q4 2025.
  • Historically, Gross Margin has averaged 73.79% across 5 years, with a median of 73.7% in 2022.
  • Annual changes were most pronounced in 2023 — Gross Margin surged 673 bps — and 2025, when it sank 935 bps.
  • Merck's Gross Margin stood at 71.94% in 2022, then rose by 2 bps to 73.26% in 2023, then increased by 3 bps to 75.5% in 2024, then decreased by 12 bps to 66.15% in 2025, then grew by 12 bps to 74.24% in 2026.
  • Business Quant data shows MRK's Gross Margin at 74.24% in Q1 2026, 66.15% in Q4 2025, and 77.69% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn 68.19%
2 AbbVie 463.46 Bn 456.89 Bn 12.70 Bn 74.74%
3 Merck 367.92 Bn 360.78 Bn 12.21 Bn 73.54%
4 Novartis Ag 297.71 Bn 290.02 Bn 11.24 Bn 78.02%
5 Astrazeneca 255.55 Bn 250.65 Bn 12.86 Bn 83.60%
6 Amgen 234.52 Bn 220.53 Bn 7.24 Bn 72.04%
7 Gilead Sciences 178.22 Bn 175.04 Bn 6.22 Bn 79.76%
8 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 72.78%
9 Gsk 105.32 Bn 101.15 Bn 8.24 Bn 73.05%
10 Sanofi 54.20 Bn 46.82 Bn 10.79 Bn 80.05%

Historic Data

Download Data
DateValue
Jun 30, 2026 73.54%
Mar 31, 2026 74.24%
Dec 31, 2025 66.15%
Sep 30, 2025 77.69%
Jun 30, 2025 77.50%
Mar 31, 2025 77.98%
Dec 31, 2024 75.50%
Sep 30, 2024 75.51%
Jun 30, 2024 76.76%
Mar 31, 2024 77.56%
Dec 31, 2023 73.26%
Sep 30, 2023 73.29%
Jun 30, 2023 73.24%
Mar 31, 2023 72.90%
Dec 31, 2022 71.94%
Sep 30, 2022 73.70%
Jun 30, 2022 71.11%
Mar 31, 2022 66.17%
Dec 31, 2021 71.35%
Sep 30, 2021 73.77%